Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

HKG:1877 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	32,332	24,805	39,550	64,674	69,569	76,812
Market Cap Growth	14.03%	-37.28%	-38.85%	-7.04%	-9.43%	266.88%
Enterprise Value	32,126	24,627	36,993	63,269	66,516	73,113
Last Close Price	21.35	11.58	19.44	48.50	58.00	56.80
PS Ratio	14.58	11.96	23.89	39.36	14.08	40.55
PB Ratio	5.32	3.93	4.90	5.85	6.82	11.10
P/TBV Ratio	5.91	4.37	5.44	6.24	7.38	11.42
EV/Sales Ratio	14.49	11.88	22.35	38.50	13.46	38.60
Debt / Equity Ratio	0.49	0.49	0.24	0.14	0.08	0.15
Asset Turnover	0.18	0.18	0.13	0.12	0.42	0.26
Inventory Turnover	0.91	0.93	1.12	0.97	3.04	1.44
Quick Ratio	1.13	1.40	1.91	3.56	2.42	2.77
Current Ratio	1.39	1.72	2.29	4.09	2.92	3.19
Return on Equity (ROE)	-21.12%	-20.83%	-29.66%	-28.57%	-10.33%	-37.90%
Return on Assets (ROA)	-7.13%	-7.65%	-12.95%	-14.56%	-4.51%	-17.07%
Return on Capital (ROIC)	-8.84%	-9.42%	-15.32%	-17.14%	-5.49%	-20.14%
Earnings Yield	-4.09%	-5.50%	-6.36%	-4.17%	-1.27%	-2.58%
FCF Yield	-5.71%	-9.12%	-7.90%	-3.79%	-2.66%	-3.15%
Buyback Yield / Dilution	-0.49%	-0.11%	-7.16%	-3.20%	-8.28%	-5.58%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.